Yvette Emerson, Université de Montréal

Research

Addiction Agonist Therapy Contingency Management High Dose Stimulant Mental Health Methamphetamine Randomized Clinical Trial

Latest funding

Addition of high dose Stimulant and engagement-focused Contingency management, alone and in combination, to treatment as usual for the management of MEthamphetamine use disorder (ASCME): a pan-Canadian multisite randomized controlled trial
CIHR · 2022 · Principal investigator
$4,986,431

All 1 grants and awards

Addition of high dose Stimulant and engagement-focused Contingency management, alone and in combination, to treatment as usual for the management of MEthamphetamine use disorder (ASCME): a pan-Canadian multisite randomized controlled trial

Principal investigatorCIHR2022Team Grant: CRISM Phase II: Regional Nodes

Principal investigators: Jutras-Aswad, Didier; de Kiewit, Alexandra; Bach, Paxton J; Bruneau, Julie; Davidson, Sara; Emerson, Yvette; Hodgins, David C; Le Foll, Bernard; Poulin, Ginette; Rehm, Jürgen T; Stewart, Sherry H; Wood, Evan

Keywords: Addiction; Agonist Therapy; Contingency Management; High Dose Stimulant; Mental Health; Methamphetamine; Randomized Clinical Trial

$4,986,431

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Mention their CIHR grant from 2022

Subject: Prospective PhD student: Addiction Dear Professor Emerson, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. Your research on addiction connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Addition of high dose Stimulant and engagement-focused Contingency management, alone and in combination, to treatment as usual for the management of MEthamphetamine use disorder (ASCME): a pan-Canadian multisite randomized controlled trial" (2022), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]